Crowdfunding triggers Capital Increase of 800,000 Euros at Rodos Biotarget

22-Aug-2017 - Germany

Rodos Biotarget is the first German life-science company to initiate crowdfunding campaigns via two crowd platforms. In 2016, a first round took place with Seedmatch, and a current financing round is running with aescuvest. With this approach, in addition to raising capital for further corporate development, Rodos Biotarget has two further objectives:

First, impact investing in the area of health economy will be opened up also for private investors within their bounds of possibilities. Second, the company wants to access business partners, collaborators, customers, and private equity through the level of attention created by crowdfunding. This has been achieved with the company entry of medical entrepreneur Otto H. Gies.

This financing round is further accompanied by High-Tech Gründerfonds and Hannover Investimpuls Fonds.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance